SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Co-Diagnostics, Inc. of Class Action Lawsuit and Upcoming Deadline – CODX
If you are a shareholder who purchased Co-Dx securities during the Class Period, you have until October 17, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
- If you are a shareholder who purchased Co-Dx securities during the Class Period, you have until October 17, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
- To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
- Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
- The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members.